Literature DB >> 17974506

Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth.

Melissa L Fishel1, Ying He, April M Reed, Helen Chin-Sinex, Gary D Hutchins, Marc S Mendonca, Mark R Kelley.   

Abstract

Apurinic endonuclease 1/redox effector factor-1 (Ape1/Ref-1 or Ape1) is an essential protein with two distinct functions. It is a DNA repair enzyme in the base excision repair (BER) pathway and a reduction-oxidation (redox) signaling factor maintaining transcription factors in an active reduced state. Our laboratory previously demonstrated that Ape1 is overexpressed in ovarian cancer and potentially contributes to resistance. Therefore, we utilized siRNA technology to knockdown protein levels of Ape1 in ovarian cancer cell line, SKOV-3x. Knocking Ape1 down had dramatic effects on cell growth in vitro but was not due to an increase in apoptosis and at least partially due to an extension in transit time through S-phase. Similarly, human ovarian tumor xenografts with reduced levels of Ape1 protein demonstrated a dramatic reduction in tumor volume (p<0.01) and also statistically significant (p=0.02) differences in (18)F-fluorodeoxyglucose (FDG) uptake indicating reduced glucose metabolism and cellular proliferation. Ape1's role in DNA repair and redox signaling is important to our basic understanding of ovarian cancer cell growth and these findings strongly support Ape1 as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974506      PMCID: PMC2247410          DOI: 10.1016/j.dnarep.2007.09.008

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  29 in total

Review 1.  DNA repair.

Authors:  Oliver Fleck; Olaf Nielsen
Journal:  J Cell Sci       Date:  2004-02-01       Impact factor: 5.285

2.  Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.

Authors:  D H Moore; H Michael; R Tritt; S H Parsons; M R Kelley
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

3.  Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.

Authors:  P Taverna; L Liu; H S Hwang; A J Hanson; T J Kinsella; S L Gerson
Journal:  Mutat Res       Date:  2001-05-10       Impact factor: 2.433

4.  A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells.

Authors:  Hua Fung; Bruce Demple
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

5.  Base excision repair as a therapeutic target in colon cancer.

Authors:  Lili Liu; Yoko Nakatsuru; Stanton L Gerson
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

Review 6.  Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway.

Authors:  Lili Liu; Stanton L Gerson
Journal:  Curr Opin Investig Drugs       Date:  2004-06

Review 7.  Recent advances in the management of women with ovarian cancer.

Authors:  G H Eltabbakh
Journal:  Minerva Ginecol       Date:  2004-02

8.  Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.

Authors:  Melissa L Fishel; Young R Seo; Martin L Smith; Mark R Kelley
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

9.  Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A.

Authors:  Zusen Fan; Paul J Beresford; Dong Zhang; Zhan Xu; Carl D Novina; Akira Yoshida; Yves Pommier; Judy Lieberman
Journal:  Nat Immunol       Date:  2003-01-13       Impact factor: 25.606

10.  Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.

Authors:  Dong Wang; Meihua Luo; Mark R Kelley
Journal:  Mol Cancer Ther       Date:  2004-06       Impact factor: 6.261

View more
  48 in total

1.  Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.

Authors:  Sarah R Mudd; Kimberley D Holich; Martin J Voorbach; Todd B Cole; David R Reuter; Paul Tapang; Gail Bukofzer; Arunava Chakravartty; Cherrie K Donawho; Joann P Palma; Gerard B Fox; Mark Day; Yanping Luo
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

2.  Characterization of the redox activity and disulfide bond formation in apurinic/apyrimidinic endonuclease.

Authors:  Meihua Luo; Jun Zhang; Hongzhen He; Dian Su; Qiujia Chen; Michael L Gross; Mark R Kelley; Millie M Georgiadis
Journal:  Biochemistry       Date:  2012-01-04       Impact factor: 3.162

Review 3.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

4.  Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1.

Authors:  Mark R Kelley; Meihua Luo; April Reed; Dian Su; Sarah Delaplane; Richard F Borch; Rodney L Nyland; Michael L Gross; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2011-01-04       Impact factor: 8.401

5.  Direct and indirect roles of RECQL4 in modulating base excision repair capacity.

Authors:  Shepherd H Schurman; Mohammad Hedayati; ZhengMing Wang; Dharmendra K Singh; Elzbieta Speina; Yongqing Zhang; Kevin Becker; Margaret Macris; Patrick Sung; David M Wilson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Hum Mol Genet       Date:  2009-06-29       Impact factor: 6.150

6.  Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.

Authors:  Melissa L Fishel; Yanlin Jiang; N V Rajeshkumar; Glenda Scandura; Anthony L Sinn; Ying He; Changyu Shen; David R Jones; Karen E Pollok; Mircea Ivan; Anirban Maitra; Mark R Kelley
Journal:  Mol Cancer Ther       Date:  2011-06-23       Impact factor: 6.261

7.  Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.

Authors:  Melissa L Fishel; Xue Wu; Cecilia M Devlin; Derek P Logsdon; Yanlin Jiang; Meihua Luo; Ying He; Zhangsheng Yu; Yan Tong; Kelsey P Lipking; Anirban Maitra; N V Rajeshkumar; Glenda Scandura; Mark R Kelley; Mircea Ivan
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

8.  Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activity.

Authors:  Courtney M Tate; Melissa L Fishel; Julianne L Holleran; Merrill J Egorin; David G Skalnik
Journal:  DNA Repair (Amst)       Date:  2009-10-15

9.  Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression.

Authors:  Mi-Hwa Kim; Hong-Beum Kim; Samudra Acharya; Hong-Moon Sohn; Jae Yeoul Jun; In-Youb Chang; Ho Jin You
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

10.  Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.

Authors:  Nicolas Aide; Laurent Poulain; Mélanie Briand; Soizic Dutoit; Stéphane Allouche; Alexandre Labiche; Aurélie Ngo-Van Do; Valérie Nataf; Alain Batalla; Pascal Gauduchon; Jean-noël Talbot; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.